Literature DB >> 15611997

Alpha(2) macroglobulin, a PSA binding protein, is expressed in human prostate stroma.

Victor K Lin1, Shih-Ya Wang, Nicholas C Boetticher, Dolores V Vazquez, Hossein Saboorian, John D McConnell, Claus G Roehrborn.   

Abstract

BACKGROUND: Benign prostatic hyperplasia (BPH) is characterized as a stromal process. The stroma smooth muscle (SM) may alter its phenotype during the progression of BPH. We have identified gene transcripts that may be differentially expressed in BPH using a differential display method. Among the fragments isolated, alpha(2) macroglobulin (alpha(2)-M) is one of the most interesting. alpha(2)-M is a binding protein of a variety of proteinases, including prostatic specific antigen (PSA). It also plays roles in molecular trapping and targeting. In this study, we characterized alpha(2)-M expression in the human prostate.
METHODS: Differential display was used to identify and isolate the differentially expressed transcripts between normal prostate and BPH tissues. RT-PCR, Western blot, in situ hybridization, and immunohistochemistry were utilized to confirm and characterize alpha(2)-M expression in the prostate.
RESULTS: Real-time RT-PCR results revealed that a 3.2-fold increase in alpha(2)-M mRNA expression is observed in BPH compared with normal prostate tissue. A 1.9-fold increase at protein level was also observed. In situ hybridization and immunohistochemistry showed that alpha(2)-M expression is primarily localized to the stromal compartment. Cultured primary stroma cells maintained alpha(2)-M expression, while prostate epithelial cells had a significantly lower level of alpha(2)-M expression. Furthermore, stromal cells in culture produce and secrete alpha(2)-M in the medium.
CONCLUSIONS: We identified alpha(2)-M expression in the human prostate. An increased alpha(2)-M expression appears to be associated with BPH. Considering the unique features of its protein binding and targeting properties, alpha(2)-M expressed in the prostate may play an important role in regulating benign and malignant prostatic growth. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15611997     DOI: 10.1002/pros.20183

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  5 in total

1.  Lessons learned about prostatic transformation from the age-related methylation of 5α-reductase type 2 gene.

Authors:  John T Isaacs
Journal:  Am J Pathol       Date:  2015-02-17       Impact factor: 4.307

2.  Ligation of prostate cancer cell surface GRP78 activates a proproliferative and antiapoptotic feedback loop: a role for secreted prostate-specific antigen.

Authors:  Uma K Misra; Sturgis Payne; Salvatore V Pizzo
Journal:  J Biol Chem       Date:  2010-11-05       Impact factor: 5.157

Review 3.  Prostate stem cells and benign prostatic hyperplasia.

Authors:  John T Isaacs
Journal:  Prostate       Date:  2008-06-15       Impact factor: 4.104

4.  Assessment of two immunodepletion methods: off-target effects and variations in immunodepletion efficiency may confound plasma proteomics.

Authors:  Bhavinkumar B Patel; Carlos A Barrero; Alan Braverman; Phillip D Kim; Kelly A Jones; Dian Er Chen; Russell P Bowler; Salim Merali; Steven G Kelsen; Anthony T Yeung
Journal:  J Proteome Res       Date:  2012-10-29       Impact factor: 4.466

5.  Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer.

Authors:  Alicia Plumer; Hongyi Duan; Sripriya Subramaniam; F Lee Lucas; Susan Miesfeldt; Ah-Kau Ng; Lucy Liaw
Journal:  BMC Cancer       Date:  2008-01-31       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.